Soleno Therapeutics (SLNO) Change in Receivables (2016 - 2017)
Historic Change in Receivables for Soleno Therapeutics (SLNO) over the last 5 years, with Q3 2017 value amounting to -$3000.0.
- Soleno Therapeutics' Change in Receivables fell 5000.0% to -$3000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was -$25790.0, marking a year-over-year decrease of 14151.17%. This contributed to the annual value of -$22790.0 for FY2016, which is 11459.71% down from last year.
- Latest data reveals that Soleno Therapeutics reported Change in Receivables of -$3000.0 as of Q3 2017, which was down 5000.0% from $23000.0 recorded in Q2 2017.
- Soleno Therapeutics' 5-year Change in Receivables high stood at $82000.0 for Q3 2015, and its period low was -$150000.0 during Q1 2014.
- For the 5-year period, Soleno Therapeutics' Change in Receivables averaged around -$1190.6, with its median value being $2109.0 (2013).
- Its Change in Receivables has fluctuated over the past 5 years, first crashed by 1735000.0% in 2014, then skyrocketed by 33157.89% in 2015.
- Quarter analysis of 5 years shows Soleno Therapeutics' Change in Receivables stood at $218.0 in 2013, then crashed by 17350.0% to -$37605.0 in 2014, then surged by 265.21% to $62127.0 in 2015, then plummeted by 136.68% to -$22790.0 in 2016, then surged by 86.84% to -$3000.0 in 2017.
- Its Change in Receivables stands at -$3000.0 for Q3 2017, versus $23000.0 for Q2 2017 and -$23000.0 for Q1 2017.